These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35754698)

  • 1. Efficacy of Modified Qingre Jiedu Decoction Combined with Three-Dimensional Conformal Radiotherapy in Treating Moderate to Advanced Ovarian Carcinoma and Its Effect on Levels of Serum Carcinoembryonic Antigen and Carbohydrate Antigen 125.
    Ai S; Xie J
    Evid Based Complement Alternat Med; 2022; 2022():1821719. PubMed ID: 35754698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis Value of Colposcope Combined with Serum Squamous Cell Carcinoma Antigen, Carbohydrate Antigen 125, and Carcinoembryonic Antigen for Moderate to Advanced Cervical Cancer Patients Treated with Modified Fuzheng Peiyuan Decoction.
    Meng H; Zhang Y; Chen Y
    Evid Based Complement Alternat Med; 2021; 2021():4355805. PubMed ID: 35003300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Efficacy of Fuzheng Guben Anticancer Decoction Combined with Taxol in Treating Ovarian Carcinoma and Its Effect on Complication Incidence.
    Li P; Lou Y
    Evid Based Complement Alternat Med; 2021; 2021():2782875. PubMed ID: 38837981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Effects of Chinese Herbal Decoction Combined with Basic Chemoradiotherapy and Nursing Intervention in the Treatment of Cervical Cancer and the Effect on Serum CEA, CA125, and TNF-
    Gao L; Lv J; Hou L; Yuan Y; Wan Q
    Evid Based Complement Alternat Med; 2021; 2021():1446864. PubMed ID: 34603461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Clinical Study on the Use of Yiqi Yangxue Decoction Combined with Chemotherapy to Promote Rapid Postoperative Recovery in Patients with Non-Small Cell Lung Cancer.
    Liang J; Wang Y; Zheng L; Mei H
    Emerg Med Int; 2022; 2022():7073893. PubMed ID: 36119912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Efficacy of Yiqi Yangyin Decoction Combined with Docetaxel on Advanced Ovarian Cancer and the Effect on the Levels of Serum Markers VEGF, HE4, and CA125.
    Wang N; Xiao F; Shao H; Shi S; Zhou Y
    J Healthc Eng; 2022; 2022():8401202. PubMed ID: 35368946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors.
    Chen F; Shen J; Wang J; Cai P; Huang Y
    Cancer Manag Res; 2018; 10():1313-1318. PubMed ID: 29861641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Psychological Intervention Combined with Dietary Guidance on Quality of Life and Long-Term Efficacy of Bushen Quyu Decoction in Treatment of Patients with Advanced Ovarian Cancer.
    Liu D; Shi G; Yin C; Liu Z; Yang A
    Evid Based Complement Alternat Med; 2021; 2021():1075513. PubMed ID: 34733335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
    Yan GY; Xu ZY; Deng HB; Wan ZY; Zhang L; Zhu JY
    Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Efficacy of Sodium Cantharidate Vitamin B6 Combined with Concurrent Chemoradiotherapy in the Treatment of Local Advanced Cervical Cancer and its Influence on Tumor Markers.
    Lu D; Chen X; Mu Y; Guo J; Zhang L
    Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38466067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of low-temperature plasma ablation combined with low-dose cisplatin chemotherapy in laryngeal carcinoma patients and its influence on tumor markers.
    Wang P; Wang G
    J BUON; 2021; 26(1):132-137. PubMed ID: 33721443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Efficacy of Modified
    Wu H; Miao X; Liu Y; Zhang S; Li C; Hao J
    Evid Based Complement Alternat Med; 2022; 2022():6234032. PubMed ID: 35571732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Dimensional Conformal Radiotherapy Combined with Gemcitabine and Docetaxel in the Treatment of Advanced Bladder Cancer and Its Effects on Inflammatory Factors and Immune Function.
    Li J; Liu M; Sun P; Zhao W; Song M; Liu Y
    J Oncol; 2022; 2022():9347218. PubMed ID: 35466316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma.
    Huang G; Chen R; Lu N; Chen Q; Lv W; Li B
    Onco Targets Ther; 2020; 13():5155-5164. PubMed ID: 32606736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
    Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of Molecular Tumor Markers CA125, HE4, and CEA with the Development and Progression of Epithelial Ovarian Cancer.
    Wan Q; Liu Y; Lv B; Chen X
    Iran J Public Health; 2021 Jun; 50(6):1197-1205. PubMed ID: 34540740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy Combined with Intracavitary Posterior Radiotherapy for the Treatment of Medium-Term and Advanced Cervical Cancer: Efficacy, Safety and Prognostic Factors.
    Yu K; Zhou L
    Front Surg; 2022; 9():906117. PubMed ID: 35677750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the application among intensity-modulated radiotherapy, 3D-conformal radiotherapy and conventional radiotherapy for locally advanced middle-low rectal cancer].
    Zhang C; Dong J; Shen T; Li Y; Yang Z; Cheng X; Luo H; Yang J; Shi Z; Wang W; Zhang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1414-1420. PubMed ID: 30588595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
    Cheong C; Shin JS; Suh KW
    World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis Can Be Predicted More Accurately Using Pre- and Postchemoradiotherapy Carcinoembryonic Antigen Levels Compared to Only Prechemoradiotherapy Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer Patients Who Received Neoadjuvant Chemoradiotherapy.
    Sung S; Son SH; Kay CS; Lee YS
    Medicine (Baltimore); 2016 Mar; 95(10):e2965. PubMed ID: 26962798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.